Guo Zhang

Guo Zhang

Auto-generated profile, based on publicly available information

Guo Zhang

Institute of Metabolism and Health, Department of Pathophysiology, School of Basic Medical Sciences, Henan University, Kaifeng, Henan, China

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in Cell
Verified
Journal Article
Closed access
XZXiaoqing Zhang
Xiaoqing Zhang
GZGuo Zhang
Guo Zhang
HZHai Zhang
Hai Zhang
MKMichael Karin
Michael Karin
HBHua Bai
Hua Bai
DCDongsheng Cai
Dongsheng Cai

1 May 2013 in Nature
Verified
Journal Article
Open access
PDF file
GZGuo Zhang
Guo Zhang
JLJuxue Li
Juxue Li
SPSudarshana Purkayastha
Sudarshana Purkayastha
YTYizhe Tang
Yizhe Tang
HZHai Zhang
Hai Zhang
DCDongsheng Cai
Dongsheng Cai
Ageing is a result of gradual and overall functional deteriorations across the body; however, it is unknown whether an individual tissue primarily works to mediate the ageing progress and control lifespan. Here we show that the hypothalamus is important for the development of whole-body ageing in mice, and that the underlying basis involves hypothalamic immunity mediated by IκB kinase-β (IKK-β), nuclear factor κB (NF-κB) and related microglia–neuron immune crosstalk. Several interventional models were developed showing that ageing retardation and lifespan extension are achieved in mice by preventing ageing-related hypothalamic or brain IKK-β and NF-κB activation. Mechanistic studies further revealed that IKK-β and NF-κB inhibit gonadotropin-releasing hormone (GnRH) to mediate ageing-related hypothalamic GnRH decline, and GnRH treatment amends ageing-impaired neurogenesis and decelerates ageing. In conclusion, the hypothalamus has a programmatic role in ageing development via immune–neuroendocrine integration, and immune inhibition or GnRH restoration in the hypothalamus/brain represent two potential strategies for optimizing lifespan and combating ageing-related health problems.

1 February 2011 in Neuron
Verified
Journal Article
Closed access
GZGuo Zhang
Guo Zhang
HBHua Bai
Hua Bai
HZHai Zhang
Hai Zhang
CDCamin Dean
Camin Dean
QWQiang Wu
Qiang Wu
DCDongsheng Cai
Dongsheng Cai

5 June 2011 in Nature Medicine
Verified
Journal Article
Open access
PDF file
SPSudarshana Purkayastha
Sudarshana Purkayastha
GZGuo Zhang
Guo Zhang
DCDongsheng Cai
Dongsheng Cai
Obesity is often associated with hypertension and this can lead to cardiovascular disease. Further, activation of a proinflammatory signaling pathway in the brain is known to contribute to obesity. Dongsheng Cai and his colleagues now show that activation of this same pathway in a certain population of neurons results in elevated blood pressure, but independently of obesity. They also show that inhibiting this activation in these neurons prevents hypertension even in the presence of obesity. Obesity-related hypertension has become an epidemic health problem and a major risk factor for the development of cardiovascular disease (CVD). Recent research on the pathophysiology of obesity has implicated a role for the hypothalamus in the pathogenesis of this condition1,2,3. However, it remains unknown whether the often-seen coupling of hypertension with obesity can also be explained by hypothalamic dysfunction, despite the emerging appreciation that many forms of hypertension are neurogenic in origin4,5,6,7,8,9,10,11,12,13. Our studies here revealed that acute activation of the proinflammatory protein nuclear factor κB (NF-κB) and its upstream activator IκB kinase-β (IKK-β, encoded by Ikbkb) in the mediobasal hypothalamus rapidly elevated blood pressure in mice independently of obesity. This form of hypothalamic inflammation-induced hypertension involved the sympathetic upregulation of hemodynamics and was reversed by sympathetic suppression. Loss-of-function studies further showed that NF-κB inhibition in the mediobasal hypothalamus counteracted obesity-related hypertension in a manner that was dissociable from changes in body weight. In addition, we found that pro-opiomelanocortin (POMC) neurons were crucial for the hypertensive effects of the activation of hypothalamic IKK-β and NF-κB, which underlie obesity-related hypertension. In conclusion, obesity-associated activation of IKK-β and NF-κB in the mediobasal hypothalamus—particularly in the hypothalamic POMC neurons—is a primary pathogenic link between obesity and hypertension. Breaking this pathogenic link may represent an avenue for controlling obesity-related hypertension and CVD without requiring obesity control.

1 November 2011 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
GZGuo Zhang
Guo Zhang
DCDongsheng Cai
Dongsheng Cai
The obesity pandemic can be viewed as a result of an imbalanced reaction to changing environmental factors. Recent research has linked circadian arrhythmicity to obesity and related diseases; however, the underlying mechanisms are still unclear. In this study, we found that high-fat diet (HFD) feeding strikingly promoted daytime rather than nighttime caloric intake in mice, leading to feeding circadian arrhythmicity. Using scheduled feeding with a defined amount of daily HFD intake, we found that an increase in the ratio of daytime to nighttime feeding promoted weight gain, whereas a decrease of this ratio rebalanced energy expenditure to counteract obesity. In identifying the underlying mechanism, we found that hypothalamic release of anorexigenic neuropeptide oxytocin displayed a diurnal rhythm of daytime rise and nighttime decline, which negatively correlated with the diurnal feeding activities of normal chow-fed mice. In contrast, chronic HFD feeding abrogated oxytocin diurnal rhythmicity, primarily by suppressing daytime oxytocin rise. Using pharmacological experiments with hypothalamic injection of oxytocin or oxytocin antagonist, we showed that daytime manipulation of oxytocin can change feeding circadian patterns to reprogram energy expenditure, leading to attenuation or induction of obesity independently of 24-h caloric intake. Also importantly, we found that peripheral injection of oxytocin activated hypothalamic oxytocin neurons to release oxytocin, and exerted metabolic effects similar to central oxytocin injection, thus offering a practical clinical avenue to use oxytocin in obesity control. In conclusion, resting-stage oxytocin release and feeding activity represent a critical circadian mechanism and therapeutic target for obesity.

31 January 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
SPSudarshana Purkayastha
Sudarshana Purkayastha
HZHai Zhang
Hai Zhang
GZGuo Zhang
Guo Zhang
ZAZaghloul Ahmed
Zaghloul Ahmed
YWYi Wang
Yi Wang
DCDongsheng Cai
Dongsheng Cai
Chronic endoplasmic reticulum (ER) stress was recently revealed to affect hypothalamic neuroendocrine pathways that regulate feeding and body weight. However, it remains unexplored whether brain ER stress could use a neural route to rapidly cause the peripheral disorders that underlie the development of type 2 diabetes (T2D) and the metabolic syndrome. Using a pharmacologic model that delivered ER stress inducer thapsigargin into the brain, this study demonstrated that a short-term brain ER stress over 3 d was sufficient to induce glucose intolerance, systemic and hepatic insulin resistance, and blood pressure (BP) increase. The collection of these changes was accompanied by elevated sympathetic tone and prevented by sympathetic suppression. Molecular studies revealed that acute induction of metabolic disorders via brain ER stress was abrogated by NF-κB inhibition in the hypothalamus. Therapeutic experiments further revealed that acute inhibition of brain ER stress with tauroursodeoxycholic acid (TUDCA) partially reversed obesity-associated metabolic and blood pressure disorders. In conclusion, ER stress in the brain represents a mediator of the sympathetic disorders that underlie the development of insulin resistance syndrome and T2D.